Focusing on oncogenic driver mutations and resistance mechanisms in the treatment of NSCLC

Lung cancer is the leading cause of cancer-related death worldwide. Improved understanding of driver mutations of non-small cell lung cancer (NSCLC) has led to more biomarker-directed treatment for patients with advanced stages.

Study finds accounting for sex improves precision and prognostic performance of CMR biomarkers for heart failure

Researchers investigated the influence of sex on cardiac magnetic resonance (CMR) assessment of left ventricular filling pressure (LVFP) in heart failure (HF) diagnosis.

May 17, 2024

Mercy & Microsoft Form Generative AI Collaboration to Advance Patient Care

What You Should Know: Microsoft Corp. and Mercy are forging a long-term collaboration using generative AI and other digital technologies to give physicians, advance practice providers and nurses

September 28, 2023

Study shows how physical activity can enhance brain function and prevent dementia

A study led by scientists at Rutgers University-New Brunswick has shown that specialized cells involved in how the body responds to insulin are activated in

January 24, 2025

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.